Celgene Archives - New Jersey Globe

Celegene sale faces some opposition

March 1, 2019 8:58 am

A major Bristol-Myers shareholder is opposing the bid to buy Celgene, the New Jersey pharmaceutical company that was run by ex-U.S. Senate Bob Hugin, the Wall Street Journal has reported. An investment firm that has an 8% stake in Bristol-Myers...

Bob Hugin named to drug maker board seat

February 19, 2019 11:59 amFebruary 19, 2019 1:03 pm

Bob Hugin, who spent $36 million of his own money last year to win 43% of the vote in a race for United States Senator, has joined the board of Allergan, a pharmaceutical company. Allergen is Parsippany-based specialty drug maker...

Menendez uses website to outline allegations against Hugin

October 3, 2018 11:48 am

The Menendez for Senate campaigns has launched a new website, HuginCancerTax.com, which lays out their research behind allegations that Republican U.S. Senate candidate Bob Hugin “gouged cancer patients and ripped off Medicare to enrich himself.” “Now we are all paying...

Menendez slams Hugin in new ad

August 22, 2018 9:10 amAugust 22, 2018 4:24 pm

Democratic U.S. Senator Bob Menendez has released his second TV ad in two days, “Greed,” which accuses his GOP opponent, Bob Hugin, of “ripping off cancer patients” while serving as CEO of Celgene, a New Jersey-based pharmaceutical company. “It’s time...

Booker calls news that Hugin discounted cancer drug in Russia a ‘mortal blow’

August 7, 2018 1:17 am

U.S. Senator Cory Booker says he was stunned by the revelation that Republican U.S. Senate candidate Bob Hugin sold a cancer drug in Russia for about the half the price in the United States. “To me, I think it’s a...

Menendez slams Hugin for discounting drugs in Russia

August 6, 2018 11:46 amAugust 6, 2018 2:27 pm

PENNINGTON – U.S. Senator Bob Menendez today called Bob Hugin’s decision to sell a life-saving cancer drug in Russia for almost half the U.S. price “outrageous” and “despicable.” The comments by the New Jersey Democrat came a day after NJ.com...

Hugin doubled price of live-saving cancer drug, report says

July 23, 2018 10:00 amJuly 23, 2018 11:49 pm

Jackie Trapp was diagnosed with multiple myeloma, a terminal but treatable blood cancer in 2015. After chemotherapy and a bone marrow transplant, she was put on Revlimid, a live-saving cancer drug that costs $21,197 a month. Even with good health...